Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.

ClinicalTrials.gov ID: NCT00464737

Public ClinicalTrials.gov record NCT00464737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel, Randomized, Double-Blind, Placebo-Controlled, Multicenter Proof of Concept Trial to Assess the Efficacy and Safety of 2 Different Doses of Rotigotine in Subjects With Signs and Symptoms Associated With Fibromyalgia Syndrome

Study identification

NCT ID
NCT00464737
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
UCB Pharma
Industry
Enrollment
230 participants

Conditions and interventions

Interventions

  • Rotigotine Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Oct 31, 2008
Completion
Oct 31, 2008
Last update posted
Jun 21, 2015

2007 – 2008

United States locations

U.S. sites
35
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Not listed Mobile Alabama
Not listed Mesa Arizona
Not listed Peoria Arizona 85381
Not listed Santa Ana California 92705
Not listed Cromwell Connecticut 06416
Not listed DeLand Florida 32720
Not listed Fort Myers Florida
Not listed Gainesville Florida 32611
Not listed Ocala Florida
Not listed Orlando Florida 32806
Not listed Palm Beach Florida
Not listed Sunrise Florida
Not listed Tampa Florida 33606
Not listed Columbia Maryland
Not listed Springfield Massachusetts 01103
Not listed St Louis Missouri 63141
Not listed Stratford New Jersey
Not listed Albuquerque New Mexico
Not listed New York New York 10022
Not listed Rochester New York
Not listed Williamsville New York
Not listed Charlotte North Carolina
Not listed Raleigh North Carolina 27612
Not listed Cleveland Ohio 44122
Not listed Dayton Ohio 45408
Not listed Oklahoma City Oklahoma 73112
Not listed Portland Oregon
Not listed Souderton Pennsylvania
Not listed Crossville Tennessee
Not listed Dallas Texas
Not listed San Antonio Texas
Not listed Bountiful Utah
Not listed Woodstock Vermont 05091
Not listed Richmond Virginia
Not listed Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00464737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2015 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00464737 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →